List of Excipients in API LONAFARNIB
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing LONAFARNIB
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Eiger BioPharmaceuticals Inc | ZOKINVY | lonafarnib | 73079-050 | CROSCARMELLOSE SODIUM | 2027-11-20 |
Eiger BioPharmaceuticals Inc | ZOKINVY | lonafarnib | 73079-050 | MAGNESIUM STEARATE | 2027-11-20 |
Eiger BioPharmaceuticals Inc | ZOKINVY | lonafarnib | 73079-050 | POLOXAMER 188 | 2027-11-20 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for LONAFARNIB
Excipient focus: CROSCARMELLOSE SODIUM
LONAFARNIB drug variants containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Eiger BioPharmaceuticals Inc | lonafarnib | 73079-050 |
>Company | >Ingredient | >NDC |
LONAFARNIB drug variants not containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
LONAFARNIB drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Eiger BioPharmaceuticals Inc | lonafarnib | 73079-050 |
>Company | >Ingredient | >NDC |
LONAFARNIB drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLOXAMER 188
LONAFARNIB drug variants containing POLOXAMER 188
Company | Ingredient | NDC |
---|---|---|
Eiger BioPharmaceuticals Inc | lonafarnib | 73079-050 |
>Company | >Ingredient | >NDC |
LONAFARNIB drug variants not containing POLOXAMER 188
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
LONAFARNIB drug variants containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
Eiger BioPharmaceuticals Inc | lonafarnib | 73079-050 |
>Company | >Ingredient | >NDC |
LONAFARNIB drug variants not containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
LONAFARNIB drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Eiger BioPharmaceuticals Inc | lonafarnib | 73079-050 |
>Company | >Ingredient | >NDC |
LONAFARNIB drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.